06Apr 2023
Mutations linked to chemotherapy resistance in colorectal cancer

Mutations linked to chemotherapy resistance in colorectal cancer

Resistance to treatment for metastatic colorectal cancer (mCRC) with trifluridine–tipiracil (FTD–TPI) is associated with mutations in KRAS codon G12 (KRASG12), new research has shown. The findings demonstrate that genomic-based markers can be used to guide chemotherapy.

  • #gastroenterology

Like

Save

Share